Predicting positive surgical margins in partial nephrectomy: A prospective multicentre observational study (the RECORd 2 project).


Journal

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
ISSN: 1532-2157
Titre abrégé: Eur J Surg Oncol
Pays: England
ID NLM: 8504356

Informations de publication

Date de publication:
07 2020
Historique:
received: 11 12 2019
accepted: 15 01 2020
pubmed: 3 2 2020
medline: 30 12 2020
entrez: 3 2 2020
Statut: ppublish

Résumé

to evaluate clinical predictors of positive surgical margins (PSMs) in a large multicenter prospective observational study and to develop a clinic nomogram to predict the likelihood of PSMs after partial nephrectomy (PN). We prospectively evaluated 4308 patients who had surgical treatment for renal tumors between January 2013 and December 2016 at 26 urological Italian Centers (RECORd 2 project). Two multivariable logistic models were evaluated to predict the likelihood of PSMs. Center caseload was dichotomized using a visual assessment adjusted for several predictors of PSMs. A nomogram predicting PSMs was developed. Overall, 2076 patients treated with PN were evaluated. pT1a, pT1b, pT2 and pT3a were recorded in 68.7%, 22.6%, 2.1% and 6.6% of the patients, respectively. PSMs were recorded in 342 (16.5%) patients. From a null multivariable model against number of PN/year, 60 PN/year were identified as the best cut-off to define a high-volume centre. At multivariable analysis, clinical stage (cT1a vs. cT2 [OR 1.94]; p = 0.03), volume centre (≤60 PN/year) (OR 2.22; p < 0.0001), imperative vs elective indication (OR 2.10; p = 0.04), surgical technique (laparoscopic vs. open [OR 1.62; p = 0.002), lymphovascular invasion (OR 2.27; p = 0.01) and upstaging to pT3a (OR 2.81; p < 0.0001) were independent predictors of PSMs. The final nomogram included age, ASA score, Charlson score, clinical tumor stage, surgical indication, surgical approach, surgical technique, PADUA score, clamp procedure and volume centre. PSMs after PN were significantly more likely in patients with lower clinical stage, higher PADUA score, in individuals referred to laparoscopic PN and in those treated at lower volume centers. We used these data to develop a nomogram to predict such risk.

Identifiants

pubmed: 32007380
pii: S0748-7983(20)30041-X
doi: 10.1016/j.ejso.2020.01.022
pii:
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1353-1359

Investigateurs

Vincenzo Altieri (V)
Francesco Berardinelli (F)
Marco Borghesi (M)
Carlo Andrea Bravi (CA)
Pierluigi Bove (P)
Giovanni Enrico Cacciamani (GE)
Riccardo Campi (R)
Antonio Celia (A)
Elisabetta Costantini (E)
Luigi Da Pozzo (L)
Mario Falsaperla (M)
Matteo Ferro (M)
Maria Furlan (M)
Simone Sforza (S)
Francesco Marson (F)
Francesco Montorsi (F)
Sebastiano Nazzani (S)
Angelo Porreca (A)
Giorgio Ivan Russo (GI)
Luigi Schips (L)
Cesare Selli (C)
Alchiede Simonato (A)
Salvatore Siracusano (S)
Carlo Trombetta (C)

Informations de copyright

Copyright © 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Auteurs

Riccardo Schiavina (R)

Department of Urology, University of Bologna, Department of Experimental, Diagnostic, and Specialty Medicine, University of Bologna, Bologna, Italy.

Andrea Mari (A)

Department of Urology, University of Florence, Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, Italy.

Lorenzo Bianchi (L)

Department of Urology, University of Bologna, Department of Experimental, Diagnostic, and Specialty Medicine, University of Bologna, Bologna, Italy.

Daniele Amparore (D)

Division of Urology, Department of Oncology, San Luigi Gonzaga Hospital, School of Medicine, Orbassano, Turin, Italy.

Alessandro Antonelli (A)

Department of Urology, Spedali Civili Hospital, University of Brescia, Brescia, Italy; Department of Urology, Azienda Ospedaliera Universitaria Integrata (A.O.U.I.), Verona, Italy.

Walter Artibani (W)

Department of Urology, Azienda Ospedaliera Universitaria Integrata (A.O.U.I.), Verona, Italy.

Eugenio Brunocilla (E)

Department of Urology, University of Bologna, Department of Experimental, Diagnostic, and Specialty Medicine, University of Bologna, Bologna, Italy.

Umberto Capitanio (U)

Unit of Urology, Division of Experimental Oncology, URI-Urological Research Institute, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Cristian Fiori (C)

Division of Urology, Department of Oncology, San Luigi Gonzaga Hospital, School of Medicine, Orbassano, Turin, Italy.

Fabrizio Di Maida (F)

Department of Urology, University of Florence, Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, Italy.

Paolo Gontero (P)

Division of Urology, Department of Surgical Sciences, San Giovanni Battista Hospital, University of Studies of Torino, Turin, Italy.

Alessandro Larcher (A)

Unit of Urology, Division of Experimental Oncology, URI-Urological Research Institute, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Vincenzo Li Marzi (V)

Department of Urology, University of Florence, Unit of Urological Minimally Invasive Robotic Surgery and Renal Transplantation, Careggi Hospital, Florence, Italy.

Nicola Longo (N)

Department of Urology, University Federico II of Naples, Naples, Italy.

Giancarlo Marra (G)

Division of Urology, Department of Surgical Sciences, San Giovanni Battista Hospital, University of Studies of Torino, Turin, Italy.

Emanuele Montanari (E)

Department of Urology, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Policlinico, University of Milan, Milan, Italy.

Francesco Porpiglia (F)

Division of Urology, Department of Oncology, San Luigi Gonzaga Hospital, School of Medicine, Orbassano, Turin, Italy.

Marco Roscigno (M)

Department of Urology, Papa Giovanni XXIII Hospital, Bergamo, Italy.

Claudio Simeone (C)

Department of Urology, Spedali Civili Hospital, University of Brescia, Brescia, Italy.

Salvatore Siracusano (S)

Department of Urology, Azienda Ospedaliera Universitaria Integrata (A.O.U.I.), Verona, Italy.

Riccardo Tellini (R)

Department of Urology, University of Florence, Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, Italy.

Carlo Terrone (C)

Department of Urology, Policlinico San Martino Hospital, University of Genova, Italy.

Donata Villari (D)

Department of Urology, University of Florence, Unit of Urological Minimally Invasive Robotic Surgery and Renal Transplantation, Careggi Hospital, Florence, Italy.

Vincenzo Ficarra (V)

Department of Human and Paediatric Pathology Gaetano Barresi, Urologic Section, University of Messina, Messina, Italy.

Marco Carini (M)

Department of Urology, University of Florence, Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, Italy.

Andrea Minervini (A)

Department of Urology, University of Florence, Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, Italy. Electronic address: andrea.minervini@unifi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH